The role of post-operative plasma full-length glypican-3 in predicting the prognosis of hepatocellular carcinoma

DOI
  • Mashima Hiroaki
    Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University
  • Mizuno Shoichi
    Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center
  • Fujinami Norihiro
    Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center
  • Saito Keigo
    Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center
  • Miura Masahiro
    Central Research Laboratories, Sysmex Corporation
  • Suto Kouzou
    Central Research Laboratories, Sysmex Corporation
  • Yoshida Tomokazu
    Central Research Laboratories, Sysmex Corporation
  • Kobayashi Tsuyoshi
    Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University
  • Ohdan Hideki
    Department of Gastroenterological and Transplant Surgery, Graduate School of Biomedical & Health Science, Hiroshima University
  • Uemura Yasushi
    Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center
  • Nakatsura Tetsuya
    Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center

Bibliographic Information

Other Title
  • 術後血漿 FL-GPC3 値による肝細胞癌予後評価法の開発

Search this article

Journal

Details 詳細情報について

Report a problem

Back to top